Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
about
Systematic review: potential preventive effects of statins against oesophageal adenocarcinomaRepurposing of approved cardiovascular drugsAnti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs.NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cells.Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.Barrett's esophagus: progression to adenocarcinoma and markers.Effect of medical and surgical treatment of Barrett's metaplasiaRisk factors and chemoprevention in Barrett's esophagus--an update.Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case-control study.Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis.Anticancer activity of a broccoli derivative, sulforaphane, in barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy.Synergic effect of eicosapentaenoic acid and lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cellsThe role of obesity in oesophageal cancer development.Pathophysiological mechanisms linking obesity and esophageal adenocarcinomaTherapeutic levels of the hydroxmethylglutaryl-coenzyme A reductase inhibitor lovastatin activate ras signaling via phospholipase D2.Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition.NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin.Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.Barrett's Esophagus: Emerging Knowledge and Management StrategiesGenomic evolution in Barrett's adenocarcinoma cells: critical roles of elevated hsRAD51, homologous recombination and Alu sequences in the genome.Atorvastatin correlates with decreased risk of esophageal cancer: a population-based case-control study from Taiwan.A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus.Simvastatin Induces Apoptosis and Suppresses Insulin-Like Growth Factor 1 Receptor in Bile Duct Cancer Cells.The prince and the pauper. A tale of anticancer targeted agents.Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial.Statins, Bcl-2, and apoptosis: cell death or cell protection?Barrett's esophagus: where do we stand?Medication usage and the risk of neoplasia in patients with Barrett's esophagus.Targeting homologous recombination and telomerase in Barrett's adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth.Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis.Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers.Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry.The role of inflammation in cancer of the esophagus.Esophageal cancer: The latest on chemoprevention and state of the art therapies.Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Oesophageal Adenocarcinoma.
P2860
Q27024919-0471C462-A0C7-4666-AFEF-B91C0F00CFEDQ28074453-DAA9CD2F-ECDE-4802-A4DA-D515F2F75A14Q33638286-8E877D65-EEB9-4882-882B-93CBE8B1F28FQ33840802-090F0764-A99A-4EAD-866A-0351DDF6F1BCQ33869277-5FDA7B53-B46C-47B9-817A-57D1C185F21DQ33905941-67B7D3E0-9488-4833-BF75-B64B5AF5E033Q34032319-D9F0C980-DF12-4870-B537-AB800E01E6C4Q34063700-673D4C70-EAD6-4C87-8963-DF7A6806F770Q34201351-2B2A52BB-95B3-4C79-ADB7-3B8DCF21A1C2Q34244183-98EF4C44-4417-4E9E-8DFB-68847CFA7E20Q34324864-C012DCF5-1F23-408B-A485-138A229836A4Q34398326-C44696FE-5709-43AD-A354-B5C9BF908C8CQ34404997-A8521443-B6F2-4E8A-A561-B6B8FB6B280EQ34418740-8AC46A2D-C919-4447-BFA4-C3BCFA7F4415Q34508880-1715A152-786F-4C5A-BB8C-634AAB16E994Q34742771-D4EC4CD1-8F81-49BF-BF35-1EE49C5D45EEQ34898182-C2E03ACB-D7CF-42EF-9F11-A39B1A2C1CB3Q35046884-82EBCB18-2418-4B0C-AF5E-D5AF47C71540Q35666515-1A3DF8B5-738C-4B1C-B46B-07160DCBFE20Q35670438-5292B376-768D-4755-9DF1-A340040671A8Q35815590-179E4602-4EF3-4AB0-8362-B08CD50F3393Q36014649-60640E5B-0E37-4F4A-A009-BD8E6C7FFE34Q36120783-0D5C0B28-64F7-48A2-9E61-64C563348ABCQ36157677-A2FBAC4F-B2D0-4279-B051-57EAD0F906F5Q36279164-420C7A2D-402C-492F-ADAA-D94686814D17Q36658462-8B78645A-D611-4BC6-9874-3816A1D324D3Q37042365-8D11B058-ABF3-4671-BC15-73E5E587332BQ37167232-4CC4FE8B-F3CE-4994-BB30-0ABDB22A6A2CQ37188822-D7CBF1CC-39EE-4445-9E25-B949C5B52C08Q37243629-76DAE341-EB68-4D10-B24C-5D9448E98BF8Q37463812-D1703FF9-E02B-48DB-A385-BCBC2C1378BFQ37614123-C400FCFE-D546-417E-BE24-55C1C6D111DFQ37621036-879E40CF-7820-4AAB-8BBC-01B760549B36Q37633568-8A4E84E5-69DE-4436-8CDD-4798C997EB80Q37843836-8A194DAB-8C17-45FB-92AD-E8760008BF0FQ37982674-1BBDBBD4-FA71-46B7-A6DB-9C7BB8D56A69Q38214324-5A74CB2C-C246-4928-AC3B-2D696D303385Q38938101-15923890-F5E1-4230-A96C-D0A5BBF39B94Q39021564-A2A29FE6-1880-4470-B687-24C3874BEBE4Q39425042-98DBAAAB-0101-4672-ADC2-E1A7119E52E0
P2860
Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Statins inhibit proliferation ...... ophageal adenocarcinoma cells.
@en
Statins inhibit proliferation ...... ophageal adenocarcinoma cells.
@nl
type
label
Statins inhibit proliferation ...... ophageal adenocarcinoma cells.
@en
Statins inhibit proliferation ...... ophageal adenocarcinoma cells.
@nl
prefLabel
Statins inhibit proliferation ...... ophageal adenocarcinoma cells.
@en
Statins inhibit proliferation ...... ophageal adenocarcinoma cells.
@nl
P2860
P1476
Statins inhibit proliferation ...... sophageal adenocarcinoma cells
@en
P2093
Ian L P Beales
P2860
P304
P356
10.1111/J.1572-0241.2007.01773.X
P407
P577
2008-03-24T00:00:00Z